CLYM Climb Bio, Inc.
Nasdaq · SEC CIK 1768446 · EDGAR
- Bought, last 12 months
- $779.6K 2 purchases by 2 insiders
- Sold, last 12 months
- $2.65M 4 sales by 2 insiders
- Filings on record
- 95 since 2021-08-11, latest 2026-09-17 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Thomas Stephen Basil | Dir | — | $2.25M |
| Kolchinsky Peter | Dir, 10% | $754.7K | — |
| Brennan Aoife | Pres, CEO, Dir | — | $407.0K |
| RA Capital Healthcare Fund LP | Dir, 10% | $24.9K | — |
Transactions 42
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-17 16:15 | 2026-09-15 | CLYM | Thomas Stephen Basil | Dir | S - Sale | $13.67 | -100.0K | 468.0K | -18% | -$1.37M |
| DT | 2026-06-30 19:50 | 2026-06-27 | CLYM | Brennan Aoife | Pres, CEO, Dir | M - OptEx | — | +68.8K | 118.6K | +138% | — |
| DT | 2026-06-30 19:50 | 2026-06-29 | CLYM | Brennan Aoife | Pres, CEO, Dir | S - Sale+OE | $13.17 | -30.9K | 87.7K | -26% | -$407.0K |
| MT | 2026-02-27 | 2026-02-25+ | CLYM | Thomas Stephen Basil | Dir | S - Sale | $7.00 | -50.0K | 154.7K | -24% | -$350.2K |
| MT | 2026-02-17 | 2026-02-12+ | CLYM | Thomas Stephen Basil | Dir | S - Sale | $5.29 | -100.0K | 204.7K | -33% | -$528.8K |
| I | 2026-01-07 | 2026-01-05 | CLYM | RA Capital Healthcare Fund LP | Dir, 10% | P - Purchase | $3.50 | +7,111 | 3.40M | +0.2% | +$24.9K |
| DMI | 2025-12-15 | 2025-12-11+ | CLYM | Kolchinsky Peter | Dir, 10% | P - Purchase | $2.40 | +314.6K | 3.29M | +11% | +$754.7K |
| DI | 2025-12-15 | 2025-12-11 | CLYM | Kolchinsky Peter | Dir, 10% | D - Sale to Iss | $0.00 | -20.44M | 3.08M | -87% | $0 |
| 2025-08-11 | 2025-08-07 | CLYM | Thomas Stephen Basil | Dir | A - Grant | $0.00 | +100.4K | 304.7K | +49% | $0 | |
| DT | 2025-07-01 | 2025-06-27 | CLYM | Brennan Aoife | Pres, CEO, Dir | M - OptEx | — | +68.8K | 68.8K | New | — |
| DT | 2025-07-01 | 2025-06-30 | CLYM | Brennan Aoife | Pres, CEO, Dir | S - Sale+OE | $1.22 | -20.6K | 48.1K | -30% | -$25.2K |
| D | 2025-07-01 | 2025-06-27 | CLYM | Thomas Stephen Basil | Dir | M - OptEx | — | +25.1K | 204.3K | +14% | — |
| DT | 2025-06-20 | 2025-06-18 | CLYM | Pimblett Emily | SVP, CAO, Fin | M - OptEx | — | +5,000 | 20.1K | +33% | — |
| DT | 2025-06-20 | 2025-06-20 | CLYM | Pimblett Emily | SVP, CAO, Fin | S - Sale+OE | $1.24 | -1,242 | 18.9K | -6% | -$1,540 |
| D | 2025-03-27 | 2025-03-27 | CLYM | Thomas Stephen Basil | Dir | M - OptEx | — | +25.1K | 179.2K | +16% | — |
| DT | 2025-03-20 | 2025-03-18 | CLYM | Pimblett Emily | SVP, CAO, Fin | M - OptEx | — | +5,000 | 16.3K | +44% | — |
| DT | 2025-03-20 | 2025-03-20 | CLYM | Pimblett Emily | SVP, CAO, Fin | S - Sale+OE | $1.31 | -1,199 | 15.1K | -7% | -$1,571 |
| D | 2025-01-03 | 2025-01-01 | CLYM | Thomas Stephen Basil | Dir | M - OptEx | — | +50.2K | 154.1K | +48% | — |
| DT | 2024-12-20 | 2024-12-18 | CLYM | Pimblett Emily | CAO | M - OptEx | — | +5,000 | 12.6K | +66% | — |
| DT | 2024-12-20 | 2024-12-19 | CLYM | Pimblett Emily | CAO | S - Sale+OE | $2.02 | -1,235 | 11.3K | -10% | -$2,495 |
| DMT | 2024-09-20 | 2024-09-20 | CLYM | Pimblett Emily | CAO | S - Sale+OE | $8.18 | -1,191 | 7,573 | -14% | -$9,741 |
| DT | 2024-09-20 | 2024-09-18 | CLYM | Pimblett Emily | CAO | M - OptEx | — | +5,000 | 8,755 | +133% | — |
| M | 2024-07-23 | 2024-07-19+ | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale | $7.65 | -129.2K | 150.3K | -46% | -$988.5K |
| M | 2024-07-19 | 2024-07-17+ | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale | $6.93 | -41.8K | 199.1K | -17% | -$289.5K |
| 2024-07-17 | 2024-07-16 | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale | $7.13 | -50.0K | 202.3K | -20% | -$356.5K | |
| M | 2024-07-16 | 2024-07-12+ | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale | $7.04 | -92.4K | 294.7K | -24% | -$650.6K |
| M | 2024-07-11 | 2024-07-09+ | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale | $6.95 | -105.9K | 394.7K | -21% | -$736.5K |
| 2024-07-09 | 2024-07-05 | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale | $7.06 | -12.3K | 450.6K | -3% | -$87.1K | |
| D | 2024-07-03 | 2024-07-01 | CLYM | Morisset Valerie | EVP, R, D AND CSO | M - OptEx | $0.00 | +7,649 | 513.0K | +2% | $0 |
| D | 2024-07-03 | 2024-07-03 | CLYM | Morisset Valerie | EVP, R, D AND CSO | S - Sale+OE | $6.76 | -50.0K | 463.0K | -10% | -$338.0K |
| MI | 2024-07-01 | 2024-06-27 | CLYM | Kolchinsky Peter | Dir, 10% | A - Grant | — | +5.26M | 11.57M | +83% | — |
| MI | 2024-07-01 | 2024-06-27 | CLYM | Kolchinsky Peter | Dir, 10% | P - Purchase | $3.84 | +13.01M | 2.87M | New | +$49.95M |
| D | 2024-06-27 | 2024-06-27 | CLYM | Thomas Stephen Basil | Dir | A - Grant | — | +103.9K | 103.9K | New | — |
| D | 2024-06-21 | 2024-06-20 | CLYM | Pimblett Emily | CAO | S - Sale+OE | $7.21 | -1,245 | 3,755 | -25% | -$8,976 |
| D | 2024-06-21 | 2024-06-18 | CLYM | Pimblett Emily | CAO | M - OptEx | — | +5,000 | 5,000 | New | — |
| D | 2024-04-08 | 2024-04-05 | CLYM | Morisset Valerie | EVP, R, D AND CSO | M - OptEx | $0.00 | +17.8K | 505.3K | +4% | $0 |
| DM | 2024-03-04 | 2023-09-20 | CLYM | Morisset Valerie | EVP, R, D AND CSO | M - OptEx | $0.00 | +20.7K | 472.2K | +5% | $0 |
| DM | 2023-03-14 | 2023-03-10 | CLYM | Morisset Valerie | EVP, CSO, R, D | M - OptEx | $0.00 | +316.4K | 466.7K | +210% | $0 |
| D | 2021-08-16 | 2021-08-12 | CLYM | Access Industries Holdings LLC | Affiliate of 10% Owner | P - Purchase | $12.50 | +800.0K | 5.01M | +19% | +$10.00M |
| D | 2021-08-16 | 2021-08-12 | CLYM | Access Industries Holdings LLC | Affiliate of 10% Owner | C - Cnv Deriv | $0.00 | +4.21M | 4.21M | New | $0 |
| DMI | 2021-08-16 | 2021-08-12 | CLYM | RA Capital Nexus Fund II, L.P. | Dir, 10% | P - Purchase | $12.50 | +3.20M | 483.7K | New | +$40.00M |
| DMI | 2021-08-16 | 2021-08-12 | CLYM | RA Capital Nexus Fund II, L.P. | Dir, 10% | C - Cnv Deriv | — | +6.87M | 288.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations